Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

Source:http://linkedlifedata.com/resource/pubmed/id/17222352

Download in:

View as

General Info

PMID
17222352